QLGN

Qualigen Therapeutics, Inc. (QLGN) | Rumor.io

Qualigen Therapeutics

QLGN

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)81%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about QLGN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% +0

Nov 17

Qualigen Therapeutics, Inc. (QLGN) is changing its name to AIxCrypto Holdings, Inc. and will trade under the new ticker symbol 'AIXC' on November 20.
The name change is part of a broader strategy to rebrand and launch an AI × Web3 strategy, with the company's majority shareholders to control the board.
QLGN will begin using its new name, AIxCrypto, and will be traded under AIXC, with a significant increase in ownership by FFAI to 63% and the company's first 100 vehicle deliveries expected before the end of the year.

Generated by AI

Sentiment

Of the messages about QLGN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0%	0%	0%	97.7% +23.9
Bearish	100%	100%	100%	2.3% -23.9

Bullish· Oct 24

Qualigen Therapeutics, Inc. (QLGN) has a strong R&D pipeline targeting high unmet clinical needs, such as pancreatic cancer, with enormous market potential if successful.
The company's partnership with BitGo to launch a multi-asset crypto treasury has ignited serious momentum, with traders circling as sentiment flips bullish and the stock up 53% pre-market.
QLGN has a low float and a microcap setup with breakout energy, potentially leading to double-digit gains if volume rips, with a target price of $7.50 and a safe entry point at $7.89.

Bearish· Nov 30

The author expects $QLGN to dip further to 1.80, where it will attract buyers.
The author believes $QLGN's recent price movement is driven by hype rather than fundamental value.
The author is dissatisfied with $QLGN's performance, comparing it unfavorably to other assets like $AERC.

Generated by AI

Topics

Of the messages about QLGN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	39.69%
Announcements	—	—	—	15.47%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	42.76%
Technical Analysis	—	—	—	2.09%

Announcements· Sep 30

Qualigen Therapeutics (QLGN) closed a $41 million PIPE financing led by Faraday Future, with Faraday contributing $30 million and its founder investing $4 million.
The deal accelerates Qualigen's new business transformation into crypto and gives Faraday Future approximately 55% ownership in Qualigen.
Qualigen's stock price jumped 18% after the announcement, with some analysts expecting a return of 5-20% following the investment.

Technical Analysis· Nov 23

$QLGN has been making higher lows, with a possible short squeeze on after-hours trading.
A cup and handle pattern on $QLGN could push the stock over $3, but it needs to play out.
$QLGN's technical chart shows a falling wedge on the 5-minute timeframe, with a possible breakout.

Generated by AI

Community

Of the messages about QLGN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	100%	26.74%
Newcomers	0%	0%	0%	73.26%

Regulars· Sep 25

$QLGN is currently trading above its VWAP and is showing strength, but needs to hold above $5.67 and push past $5.80 for a potential follow-through.
The stock is grinding higher in a steady intraday uptrend, holding above its trendline and VWAP, but the zone to watch is $4.90 for potential continuation.
A potential breakout above $5.90 is possible if $QLGN's ascending base holds, with the stock consolidating in a higher low pattern just above VWAP.

Newcomers· Oct 24

$QLGN is a high-conviction trade for the month, with the potential to reach $3 by Monday.
The company's stock price has been affected by market fluctuations, with some users experiencing losses, but others seeing potential for growth.
There are concerns among shareholders about the company's use of funds, with some users calling for answers about the return on investment.

Generated by AI

Also Discussed

Investors talking about QLGN also mention

#	Name	Attention
1	Longeveron Inc. Class A Common StockLGVN	0%0
2	PTPI - Petros Pharmaceuticals, Inc.	——
3	Pioneer Power Solutions Inc.PPSI	0%new
4	iSpecimen Inc.ISPC	0%0
5	Pasithea Therapeutics Corp.KTTA	0%0
6	BeyondSpring Inc.BYSI	0%0
7	Inspira Technologies Oxy B.H.N. Ltd.IINN	0%new
8	Biomerica Inc.BMRA	0%0
9	GRCL - Gracell Biotechnologies Inc.	——
10	NRx Pharmaceuticals, Inc.NRXP	0%-0.01